Effects of Semaglutide on Stroke Subtypes in Type 2 Diabetes: Post Hoc Analysis of the Randomized SUSTAIN 6 and PIONEER 6

• Published in: Stroke (1970) Vol. 53; no. 9; pp. 2749 - 2757
• Main Authors: Strain, W. David, Frenkel, Ofir, James, Martin A., Leiter, Lawrence A., Rasmussen, Søren, Rothwell, Peter M., Sejersten Ripa, Maria, Truelsen, Thomas C., Husain, Mansoor
• Format: Journal Article
• Language: English
• Published: United States Lippincott Williams & Wilkins 01.09.2022
• Subjects: Clinical Trials; blood pressure; prevalence; peptides; atrial fibrillation; myocardial infarction

GLP-1 RA (glucagon-like peptide-1 receptor agonists), including semaglutide, may reduce stroke risk in people with type 2 diabetes. This post hoc analysis examined the subcutaneous and oral semaglutide effects, versus placebo, on stroke and its subtypes in people with type 2 diabetes at high cardiov...